Zobrazeno 1 - 10
of 143
pro vyhledávání: '"анализ «влияния на бюджет»"'
Autor:
Yu. A. Zabolotneva, I. S. Krysanov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 40-51 (2024)
Purpose of the study. Conducting an assessment of the economic consequences (clinical and economic analysis) when conducting cytogenetic studies before prescribing various first-line treatment regimens for multiple myeloma (MM). Materialsand methods.
Externí odkaz:
https://doaj.org/article/0439bbc4b0f04695b2c20a66bd0bdf14
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 4-15 (2021)
Background. Mucopolysaccharidosis Type I (MPS I) has clinical heterogeneity without specific symptoms leading to difficulties with diagnostic on time. In-depth screening for MPS I in children has aim of early detection and timely treatment with an en
Externí odkaz:
https://doaj.org/article/573e32376c5e49b896b4bbe4d5fcd35b
Autor:
I. N. Dyakov, G. R. Kasyan
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 35-45 (2021)
Objective: to assess the clinical and economic efficiency and impact on the budget when using the drug Mirabegron in the treatment of an overactive bladder. Materials and methods. Study design — retrospective analysis of published data. Pharmacoeco
Externí odkaz:
https://doaj.org/article/f70e0d9faa3d40f08b7655ffe8d56879
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 5, Pp 50-63 (2021)
Ipragliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduce plasma glucose concentrations by inhibiting glucose reabsorption by the kidney through inhibiting SGLT2 sodium-glucose cotransporter and induce glycosuria. SGLT
Externí odkaz:
https://doaj.org/article/3326312b1b5c4b98a97d9ae02c8e1e68
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 40-51 (2020)
Aim. To assess the pharmacoeconomic feasibility of including the drug upadacitinib in restrictive lists and government funding programs to provide patients with rheumatoid arthritis.Materials and methods. Study Design — Retrospective Analysisof Lit
Externí odkaz:
https://doaj.org/article/6730714bb93a47e5aba8f30767e5f092
Autor:
S. K. Zyryanov, I. N. Dyakov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 23-32 (2020)
Purpose. To evaluate pharmacoeconomic efficiency of dapagliflosin application for intensification of hypoglycemic therapy — in comparison with addition to therapy of group of inhibitors of dipeptidyl peptidase 4 (iDPP-4) or basal insulin. Materials
Externí odkaz:
https://doaj.org/article/3f767d02106741f1a1fbcf6ec3d902ea
Autor:
A. E. Cheberda, D. U. Belousov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 23-31 (2020)
Gadolinium-based contrast compounds are paramagnetic chemicals that allow enhancing contrast during magnetic resonance imaging (MRI) tomographic investigation. It`s known that linear gadolinium-based paramagnetic compounds cause permanent accumulatio
Externí odkaz:
https://doaj.org/article/3ade728010bb4236a5560d578f6bf0a9
Autor:
S. K. Zyryanov, I. N. Dyakov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 4-14 (2019)
Fixed antidiabetic drugs’ combinations have aim to improve Diabetes Mellitus type 2 (DMT2) control as well as a safety treatment increasing. Soliqua SoloStar® is a new registered drug for control fasting and prandial glucose levels, contained insu
Externí odkaz:
https://doaj.org/article/2949043da2b349a0a83c3e8c90d40dff
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 55-68 (2019)
Objective. To perform the pharmacoeconomic analysis of ceftolosan + tazobactam (Zerbaxa®) compared with the routine practice of antibacterial therapy of complicated intra-abdominal infections (clAI) and ceftazidime + avibactam (Zavicefta®).Methods.
Externí odkaz:
https://doaj.org/article/91c549683a7e4ed7b8a517ecc5d8ce6b
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 14-24 (2019)
Actuality. A major problem for rehabilitating patients after a stroke, other major cerebrovascular events or trauma (such as traumatic brain injury (TBI)) is increased muscle tone (spasticity) which in turn causes impairments of mobility and formatio
Externí odkaz:
https://doaj.org/article/a40878daa3934c5da9379eb838899994